Table 3.
Variable | Pre-ACCESS, n (%) | Post-ACCESS, n (%) | Change, n (%) | P value |
---|---|---|---|---|
Number of cases, n |
1685 |
1624 |
-61 (-4) |
- |
Number of cases by priority level, n (%) |
|
|
|
<0.0001 |
P2 |
187 (11) |
95 (6) |
-92 (-49) |
|
P3 |
1027 (61) |
768 (47) |
-259 (-25) |
|
P4 |
471 (28) |
761 (47) |
+290 (+62) |
|
No. of cases exceeding wait-time targets by priority, n (%) |
|
|
|
0.39 |
P2 |
120 (64) |
61 (64) |
-59 (-49) |
|
P3 |
485 (47) |
297 (39) |
-188 (-39) |
|
P4 |
122 (26) |
118 (16) |
-4 (-3) |
|
Median wait-times by priority, days (range) |
|
|
|
0.52 |
P2 |
19 (1–215) |
17 (1–55) |
-2 (-10) |
|
P3 |
27 (0–274) |
23 (0–108) |
-4 (-14) |
|
P4 |
66 (0–246) |
41 (0–207) |
-25 (-37) |
|
Type of cancer, n (%) |
|
|
|
< 0.0001 |
Gastric |
21 (1) |
10 (0.6) |
-11 (-52) |
|
Endocrine |
238 (14) |
172 (11) |
-66 (-28) |
|
Genitourinary (excluding prostate) |
228 (14) |
230 (14) |
+2 (+1) |
|
Gynecological |
350 (21) |
284 (17) |
-66 (-19) |
|
Head and neck (excluding thyroid) |
154 (9) |
276 (17) |
+122 (+79) |
|
Lung |
168 (10) |
194 (12) |
+26 (+15) |
|
Lymph |
2 (0.1) |
3 (0.2) |
+1 (+50) |
|
Peripheral nervous system |
1 (0.1) |
3 (0.2) |
+2 (+200) |
|
Prostate |
132 (8) |
105 (6) |
-27 (-20) |
|
Skin carcinoma1 |
8 (0.5) |
7 (0.4) |
-1 (-13) |
|
Skin melanoma | 49 (3) | 30 (2) | -19 (-39) |
1Includes basal and squamous cell carcinoma.